Key result
Serum creatinine remains the most important, feasible, and inexpensive determinant for assessing perioperative renal function and predicting adverse outcomes in cardiac surgery.
Why the study?
Does serum creatinine measurement predict adverse outcomes and acute kidney injury in patients undergoing cardiac surgery?
Does serum creatinine measurement predict adverse outcomes and acute kidney injury in patients undergoing cardiac surgery?
Despite the study of many novel biomarkers, serum creatinine remains the mainstay for predicting perioperative renal function and adverse outcomes in cardiac surgery.
Serum creatinine should remain the primary perioperative renal marker in cardiac surgery; leaves open the incremental value of novel biomarkers.
Serum creatinine is still the most important determinant in the assessment of perioperative renal function and in the prediction of adverse outcome in cardiac surgery. Many biomarkers have been studied to date; still, there is no surrogate for serum creatinine measurement in clinical practice because it is feasible and inexpensive. High levels of serum creatinine and its equivalents have been the most important preoperative risk factor for postoperative renal injury. Moreover, creatinine is the mainstay in predicting risk models and risk factor reduction has enhanced its importance in outcome prediction. The future perspective is the development of new definitions and novel tools for the early diagnosis of acute kidney injury largely based on serum creatinine and a panel of novel biomarkers.
No takes yet. Share an insight, caveat, or question.
Mahdi Najafi (2014) conducted a review in Cardiac surgery. Serum creatinine measurement was evaluated. Serum creatinine remains the most important, feasible, and inexpensive determinant for assessing perioperative renal function and predicting adverse outcomes in cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: